The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Epidemiology and natural history of central venous access device (CVAD) use and infusion pump performance among patients (pts) treated for metastatic colorectal cancer (mCRC): Analysis from the NO16966 trial.
E. Chu
Consultant or Advisory Role - Roche
Honoraria - Roche
D. G. Haller
Consultant or Advisory Role - Roche
Honoraria - Genentech; Roche
Research Funding - Roche
T. H. Cartwright
Consultant or Advisory Role - Roche
Honoraria - Roche
C. Twelves
Consultant or Advisory Role - Roche
Honoraria - Roche
Other Remuneration - conference eg. ASCO travel
E. McKenna
Employment or Leadership Position - Genentech
N. Scotto
Employment or Leadership Position - Roche
F. Gilberg
Employment or Leadership Position - Roche
J. Cassidy
Consultant or Advisory Role - Amgen; Roche; Sanofi
Honoraria - Amgen; Roche; Sanofi
Research Funding - Amgen; Roche; Sanofi
W. Sun
Consultant or Advisory Role - Genentech; Roche
Honoraria - Genentech; Roche
M. W. Saif
Honoraria - Genentech; Roche
Research Funding - Roche
H. Schmoll
No relevant relationships to disclose